Literature DB >> 26257912

Histamine-functionalized copolymer micelles as a drug delivery system in 2D and 3D models of breast cancer.

Yuning Zhang1, Pontus Lundberg2, Maren Diether1, Christian Porsch3, Caroline Janson2, Nathaniel A Lynd2, Cosimo Ducani4, Michael Malkoch3, Eva Malmström3, Craig J Hawker2, Andreas M Nyström1.   

Abstract

Histamine functionalized block copolymers based on poly(allyl glycidyl ether)-b-poly(ethylene oxide) (PAGE-b-PEO) were prepared with different ratios of histamine and octyl or benzyl groups using UV-initiated thiol-ene click chemistry. At neutral pH, the histamine units are uncharged and hydrophobic, while in acidic environments, such as in the endosome, lysosomes, or extracellular sites of tumours, the histamine groups are positively charged and hydrophilic. pH responsible polymer drug delivery systems is a promising route to site specific delivery of drugs and offers the potential to avoid side effects of systemic treatment. Our detailed in vitro experiments of the efficacy of drug delivery and the intracellular localization characteristics of this library of NPs in 2D and 3D cultures of breast cancer revealed that the 50% histamine-modified polymer loaded with DOX exhibited rapid accumulation in the nucleus of free DOX within 2 h. Confocal studies showed enhanced mitochondrial localization and lysosomal escape when compared to controls. From these combined studies, it was shown that by accurately tuning the structure of the initial block copolymers, the resulting self-assembled NPs can be designed to exploit histamine as an endosomal escape trigger and the octyl/benzyl units give rise to a hydrophobic core resulting in highly efficacious drug delivery systems (DDS) with control over intracellular localization. Optimization and rational control of the intracellular localization of both DDS and the parent drug can give nanomedicines a substantial increase in efficacy and should be explored in future studies.

Entities:  

Year:  2015        PMID: 26257912      PMCID: PMC4527560          DOI: 10.1039/C4TB02051K

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  70 in total

1.  Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy.

Authors:  Liming Wang; Ying Liu; Wei Li; Xiumei Jiang; Yinglu Ji; Xiaochun Wu; Ligeng Xu; Yang Qiu; Kai Zhao; Taotao Wei; Yufeng Li; Yuliang Zhao; Chunying Chen
Journal:  Nano Lett       Date:  2010-12-27       Impact factor: 11.189

2.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

3.  Assessment of the toxicity of silver nanoparticles in vitro: a mitochondrial perspective.

Authors:  João S Teodoro; Anabela M Simões; Filipe V Duarte; Anabela P Rolo; Richard C Murdoch; Saber M Hussain; Carlos M Palmeira
Journal:  Toxicol In Vitro       Date:  2011-01-11       Impact factor: 3.500

4.  N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.

Authors:  Ji Sun Park; Tae Hee Han; Kuen Yong Lee; Sung Soo Han; Jung Jin Hwang; Dae Hyuk Moon; Sang Yoon Kim; Yong Woo Cho
Journal:  J Control Release       Date:  2006-07-20       Impact factor: 9.776

5.  Acid pH in tumors and its potential for therapeutic exploitation.

Authors:  I F Tannock; D Rotin
Journal:  Cancer Res       Date:  1989-08-15       Impact factor: 12.701

6.  pH-responsive Multi-PEGylated dual cationic nanoparticles enable charge modulations for safe gene delivery.

Authors:  May P Xiong; Younsoo Bae; Shigeto Fukushima; M Laird Forrest; Nobuhiro Nishiyama; Kazunori Kataoka; Glen S Kwon
Journal:  ChemMedChem       Date:  2007-09       Impact factor: 3.466

7.  Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs.

Authors:  Neil Ashley; Joanna Poulton
Journal:  Biochem Biophys Res Commun       Date:  2008-11-24       Impact factor: 3.575

Review 8.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

9.  Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.

Authors:  Hae Yun Nam; Seok Min Kwon; Hyunjin Chung; Seung-Young Lee; Seung-Hae Kwon; Hyesung Jeon; Yoonkyung Kim; Jae Hyung Park; Joon Kim; Songwook Her; Yu-Kyoung Oh; Ick Chan Kwon; Kwangmeyung Kim; Seo Young Jeong
Journal:  J Control Release       Date:  2009-02-03       Impact factor: 9.776

10.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Authors:  Y Matsumura; H Maeda
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

View more
  2 in total

1.  Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer.

Authors:  Man Ao; Xu Xiao; Yazhou Ao
Journal:  Braz J Med Biol Res       Date:  2018-01-23       Impact factor: 2.590

2.  Off-Stoichiometric Thiol-Ene Chemistry to Dendritic Nanogel Therapeutics.

Authors:  Yuning Zhang; Oliver C J Andrén; Randi Nordström; Yanmiao Fan; Martin Malmsten; Surinthra Mongkhontreerat; Michael Malkoch
Journal:  Adv Funct Mater       Date:  2019-03-07       Impact factor: 19.924

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.